Surrozen Inc

XNAS:SRZN 4:00:00 PM EDT

21.62

-2.98 (-12.10%)

4:56:18 PM EDT: $22.00 +0.39 (+1.78%)

Market Cap (Intraday)	185.27M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.5 Million
Adjusted EPS	-$1.30

See more estimates

10-Day MA	$21.00
50-Day MA	$15.02
200-Day MA	$11.35

See more pivots

Surrozen Inc Stock, XNAS:SRZN

171 Oyster Point Boulevard, Suite 400, South San Francisco, California 94080

United States of America

Phone: +1.650.489.9000

Number of Employees: 42

http://www.surrozen.com

Description

Surrozen, Inc. is a clinical stage biotechnology company. It engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K. Christopher Garcia and Roeland Nusse on August 12, 2015 and is headquartered in South San Francisco, CA.